Catalyst Wire Dossier Catalyst Wire Dossier

CCR5-modified CD4+ T cells

· University of Cincinnati
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCR5-modified CD4+ T cells, covering 2024-05-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: CCR5-modified CD4+ T Cells for HIV Infection [Phase 1, Phase 2]

See pricing